Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

Unconditional accreditation for Architecture at the UFS
2008-08-20

The Department of Architecture at the University of the Free State (UFS) is so far the only department of its kind in the country to obtain unconditional accreditation from the South African Council for the Architecture Profession (SACAP) for all three its programmes.

“SACAP has already visited seven out of a possible ten institutions in the country who present Architecture. Of these, only the UFS’s Department of Architecture has so far received unconditional accreditation. This is indeed an achievement for us,” said Prof. Jan Smit, Head of the Department.

According to Prof. Smit, the SACAP’s evaluation of all institutions who offer Architecture takes place every four years. During the accreditation process in 2004, the department also received unconditional accreditation for the two programmes it presented at that stage, namely the B.A.S. degree and the B.Arch. degree. Since then, the B.Arch. degree has fallen away and the qualifications the department now offers are the B.A.S. degree, B.A.S. (Hons.) and the M.Arch.(Prof.).

“The unconditional accreditation serves as proof that the qualifications obtained by our students are of value and that it enjoys local and international recognition. It is also an indication that our students’ training is up to standard,” said Prof. Smit.

The criteria students are evaluated on includes the facilities, degrees and courses presented, the standard of exam papers and assignments of a subject, the style of management and staff compilation. The panel of judges comprise of among others a representative from the Commonwealth Association of Architects (CAA), who reports to the Royal Institute of British Architects (RIBA). “This is an indication of the high level on which the evaluation is being done,” said Prof. Smit.


Media Release
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za  
20 August 2008
 

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept